At our July event Davina Bonner, Manager Research Grants, gave us an update. Dr Naomi Paxton and PhD Candidate Jonathan Gospos delivered interesting research presentations. Watch the video from the event:
Congratulations to PhD Candidate, Lucy Yong on receiving the CBT Outstanding HDR Award July 2023
During June CBT hosted two high school students from Loreto College for a week of work experience. Lucy was asked to supervise and mentor the girls for the week; she was the perfect role model and buddy adding a valued HDR perspective to the program. Lucy is a great advocate for young women in STEM and keen to be involved in future collaborations with high school students. (Nominated by Julie Mitchell)
Watch a video with the year 10 students:
Sharing is caring
The CBT Lunch Club offers our HDR students and early career researchers an opportunity to network with like-minded, give practice talks and be inspired by external presenters. The sessions are arranged by Dr Jacqui McGovern and Dr Nathalie Bock, CBT Internal Engagement Leads. Learn more.
More about the speakers:
Research Grants at QUT
Davina Bonner is a Manager of Research Grants in the Office of Research Services at QUT. In this role, she provides guidance and support to QUT researchers throughout the entire research grant life-cycle. Additionally, she develops and implements systems and processes that ensure the submission of large volumes of high-quality grant applications. From developing grant applications to managing awards, Davina ensures that researchers have the resources and tools they need to succeed. Her role is particularly focused on fellowships and international research grants, and she has extensive experience navigating the funding landscape. However, her knowledge and skills extend beyond these areas, and she is well-equipped to assist with a wide range of research grants. Davina enjoys engaging with researchers and learning about their work. She is always available to answer questions and provide assistance with research grant applications.
Printing My Way Across the Pacific: A postdoc’s tale of medical 3D printing in the US
Dr Naomi Paxton is a Postdoctoral Research Fellow at QUT in the field of biofabrication & biomedical engineering applications of 3D printing. With experience working in research labs in Australia, Germany, the UK and the USA, Naomi is an early career researcher designing 3D printed implants that stimulate rapid regeneration of large bone fractures, soft tissue injuries, and diseased tissues to permanently restore their mechanical and biological functionality. Naomi’s 3D printing research further enables surgeons to plan and practice surgical procedures on personalized models, reducing the likelihood of surgical errors and rehabilitation time for patients. Naomi’s transdisciplinary research, spanning biofabrication, engineering and materials science, is accelerating medical 3D printing technologies to advance hospital-based personalized medical device manufacturing.
Tissue engineering a rat model for osteosarcoma research: an insight into the destructive nature of this cancer through advanced imaging techniques.
Jonathan Gospos is a motivated and high-achieving individual with over 15 years in the health industry. He is both a registered radiographer and pharmacist, with a proven track record of academic and professional achievements. Jonathan embarked on PhD research as he wanted to combine my clinical background as he has a passion to help patients not only face to face, but to make a greater impact with translational research. During his PhD, he developed an advanced osteosarcoma (rat) model that converges tissue engineering and regenerative medicine principles to allow comparison of treatment regimes. Currently, Jonathan is investigating the efficacy of scaffold-mediated local chemotherapy delivery following surgical resection of the primary OS tumour. The tumour will be removed from the femur by dissecting a 6 mm segmental defect, then stabilised with an intramedullary nail and a Doxorubicin (DOX)-loaded defect-bridging scaffold. The ability of local DOX delivery to prevent OS reoccurrence will be compared to standard systemic chemotherapy treatment. The defect zone will then be replaced with a scaffold to regenerate the bone.